3
158
C. Xie et al.
LETTER
Supporting Information for this article is available online at
http://www.thieme-connect.com/ejournals/toc/synlett.
(7) (a) Ghosh, A.; Sieser, J. E.; Riou, M.; Cai, W.; Rivera-Ruiz,
L. Org. Lett. 2003, 5, 2207. (b) Cacchi, S.; Fabrizi, G.;
Goggiamani, A.; Zappia, G. Org. Lett. 2001, 3, 2539.
(c) Moreno-Mañas, M.; Morral, L.; Pleixats, R.; Villarroya,
Acknowledgment
S. Eur. J. Org. Chem. 1999, 181. (d) Larksarp, C.; Alper, H.
J. Am. Chem. Soc. 1997, 119, 3709. (e) Trost, B.; Sudhakar,
A. R. J. Am. Chem. Soc. 1988, 110, 7933.
This work was supported by the Natural Science Foundation of
P. R. of China (No. 20675022) and Zhejiang Provincial Foundation
of China (No. 2007C01004-2).
(
(
8) (a) Ghosh, A.; Sieser, J. E.; Caron, S.; Couturier, M.;
Dupont-Gaudet, K.; Girardin, M. J. Org. Chem. 2006, 71,
1258. (b) Mallesham, B.; Rajesh, B. M.; Rajmohan Reddy,
P.; Srinivas, D.; Trehan, S. Org. Lett. 2003, 5, 963.
9) (a) Yamanaka, H.; Yamane, Y.; Mukaiyama, T.
Heterocycles 2004, 63, 2813. (b) Matsuo, J.; Yamanaka, H.;
Kawana, A.; Mukaiyama, T. Chem. Lett. 2003, 32, 392.
References and Notes
(
1) (a) Mukhtar, T. A.; Wright, G. D. Chem. Rev. 2005, 105,
29. (b) Brickner, S. J. Curr. Pharm. Des. 1996, 2, 175.
5
(
c) Rowbottom, M. W.; Mathews, N.; Gallagher, T. J. Chem.
(2) (a) Tucker, J. A.; Allwine, D. A.; Grega, K. C.; Barbachyn,
M. R.; Klock, J. L.; Adamski, J. L.; Brickener, S. J.;
Soc., Perkin Trans. 1 1998, 3927. (d) Garst, M. E.;
Arrhenius, P. J. Org. Chem. 1983, 48, 19. (e) Braun, H.;
Huber, G. Tetrahedron Lett. 1976, 17, 2121.
Hutchinson, D. K.; Ford, C. W.; Zurenko, G. E.; Conradi,
R. A.; Burton, P. S.; Jensen, R. M. J. Med. Chem. 1998, 41,
(
(
(
10) Wang, Y. F.; Zhang, W. H.; Colandrea, V. J.; Jimenez, L. S.
Tetrahedron 1999, 55, 10659.
11) Kim, K. H.; Jimenez, L. S. Tetrahedron: Asymmetry 2001,
3727. (b) Genin, M. J.; Hutchinson, D. K.; Allwine, D. A.;
Hester, J. B.; Hemmert, D. E.; Garmon, S. A.; Ford, C. W.;
Zurenko, G. E.; Hamel, J. C.; Schaadt, R. D.; Stapert, D.;
Yagi, B. H.; Friis, J. M.; Shobe, E. M.; Adams, W. J. J. Med.
Chem. 1998, 41, 5144. (c) Gleave, D. M.; Brickner, S. J.;
Manninen, P. R.; Allwine, D. A.; Lovasz, K. D.; Rohrer,
D. C.; Tucker, J. A.; Zurenko, G. E.; Ford, C. W. Bioorg.
Med. Chem. Lett. 1998, 8, 1231. (d) Brickner, S. J.;
Hutchinson, D. K.; Barbachyn, M. R.; Manninen, P. R.;
Ulanowicz, D. A.; Garmon, S. A.; Grega, K. C.; Hendges,
S. K.; Toops, D. S.; Ford, C. W.; Zurenko, G. E. J. Med.
Chem. 1996, 39, 673. (e) Gleave, D. M.; Brickner, S. J.
J. Org. Chem. 1996, 61, 6470.
1
2, 999.
12) (a) Yar, M.; McGarrigle, E. M.; Aggarwal, V. K. Org. Lett.
009, 11, 257. (b) Yar, M.; McGarrigle, E. M.; Aggarwal,
2
V. K. Angew. Chem. Int. Ed. 2008, 47, 3784. (c) Unthank,
M. G.; Tavassoli, B.; Aggarwal, V. K. Org. Lett. 2008, 10,
1501. (d) Unthank, M. G.; Hussain, N.; Aggarwal, V. K.
Angew. Chem. Int. Ed. 2006, 45, 7066.
(
(
13) (a) Campbell, A. L.; Lenz, G. R. Synthesis 1987, 421.
(
b) Robiette, R.; Cheboub-Benchaba, K.; Peeters, D.;
Marchand-Brynaert, J. J. Org. Chem. 2003, 68, 9809.
c) Nguyen, T. B.; Martel, A.; Dhal, R.; Dujardin, G. J. Org.
(
(
3) Ali, A.; Reddy, G. S. K. K.; Cao, H.; Anjum, S. G.; Nalam,
M. N. L.; Schiffer, C. A.; Rana, T. M. J. Med. Chem. 2006,
Chem. 2008, 73, 2621.
14) Typical Procedure for the Tandem Reactions – Synthesis
of 3-Phenyloxazolidin-2-one
4
9, 7342.
4) (a) Burke, C. P.; Shu, L.-H.; Shi, Y.-A. J. Org. Chem. 2007,
2, 6320. (b) Shu, L.-H.; Wang, P.-Z.; Gan, Y.-H.; Shi,
(
tert-Butyl phenylcarbamate (96 mg, 0.5 mmol) and Et N
7
3
(
152 mg, 1.5 mmol) were charged into an oven-dried flask,
Y.-A. Org. Lett. 2003, 5, 293. (c) Poindexter, G. S.; Owens,
D. A.; Dolan, P. L.; Woo, E. J. Org. Chem. 1992, 57, 6257.
5) (a) Nicolaou, K. C.; Zhong, Y.-L.; Baran, P. S. Angew.
Chem. Int. Ed. 2000, 39, 625. (b) Jegham, S.; Nedelec, A.;
Burnier, P.; Guminski, Y.; Puech, F.; Koenig, J. J.; George,
P. Tetrahedron Lett. 1998, 39, 4453. (c) Schaus, S. E.;
Jacobsen, E. N. Tetrahedron Lett. 1996, 37, 7937.
6) (a) Brickner, S. J.; Hutchinson, D. K.; Barbachyn, M. R.;
Manninen, P. R.; Ulanowicz, D. A.; Garmon, S. A.; Grega,
K. C.; Hendges, S. K.; Toops, D. S.; Ford, C. W.; Zurenko,
G. E. J. Med. Chem. 1996, 39, 673. (b) Griera, R.; Cantos-
Llopart, C.; Amat, M.; Bosch, J.; Del Castillob, J. C.;
Huguet, J. Bioorg. Med. Chem. Lett. 2005, 15, 2515.
followed by the addition of CH Cl (2 mL) under the
2
2
protection of nitrogen atmosphere to form a solution. The
solution of diphenyl vinyl sulfonium triflate (543 mg, 1.5
(
(
mmol) in CH Cl (3 mL) was added into the above solution
2
2
by syringe under N at r.t. The reaction mixture was then put
2
into a 45 °C oil bath to react for 24 h. After the completion
of reaction, the solvent was removed under reduced
pressure. The residue was then separated on a silica gel
column by using PE–EtOAc (1:2) as eluent, and the final
product was obtained as pale yellow powder (42 mg, 52%).
1
H NMR (400 MHz, CDCl , TMS): d = 7.51 (d, J = 8.0 Hz,
3
2
(
H), 7.36 (t, J = 8.0 Hz, 2 H), 7.12 (t, J = 7.4 Hz, 1 H), 4.42
1
3
t, J = 8.0 Hz, 2 H), 3.99 (t, J = 8.0 Hz, 2 H). C NMR (100
(
c) Perrault, W. R.; Pearlman, B. A.; Godrej, D. B.;
MHz, CDCl ): d = 155.3, 138.3, 129.1, 124.1, 118.2, 61.3,
Jeganathan, A.; Yamagata, K.; Chen, J.-J.; Lu, C. V.;
Herrinton, P. M.; Gadwood, R. C.; Chan, L.; Lyster, M. A.;
Maloney, M. T.; Moeslein, J. A.; Greene, M. L.; Barbachyn,
M. R. Org. Process Res. Dev. 2003, 7, 533.
3
+
4
5.2. HRMS (EI): m/z calcd for C H NO [M] : 163.0633;
9 9 2
found: 163.0627.
Synlett 2009, No. 19, 3155–3158 © Thieme Stuttgart · New York